Chris joined Takeda in 2015 from Sanofi, where he established and oversaw multiple partnerships and led groups in the USA and France focused on the development of novel immunotherapies for cancers and inflammatory diseases.  In Takeda, he is responsible for Immunology research across three therapeutic areas and research sites, and he also leads the Oncology Drug Discovery Unit, based in Cambridge, MA. Chris obtained his PhD in Immunology from the University of Alberta, Canada, and carried out his postdoctoral training with Dan Littman at the Skirball Institute of NYU Medical Center, New York.  He has 15 years of Industry experience advancing novel therapeutics to the clinic.